Ademi & Fruchter LLP Continues to Investigate Claims of Securities Fraud against UnitedHealth Group Incorporated

Ademi & Fruchter LLP is investigating possible securities fraud claims against UnitedHealth (NYSE: UNH). The investigation results from inaccurate statements UnitedHealth made regarding its business operations and prospects.

Click here to join our investigation or to obtain additional information, or contact us at [e-mail] or toll-free: 866-264-3995. There is no cost or obligation to you.

The investigation focuses on UnitedHealth’s recent revisions to its financial forecast for 2025, the resignation of CEO Andrew Witty and the suspension of full-year guidance. UnitedHealth has already admitted its recent performance has been “unusual and unacceptable,” and analysts are calling the revisions “really surprising” and caused by “executional errors.” Former CEO Stephen Hemsley will replace Witty and said on a call today, “I'm deeply disappointed and apologize for the performance setbacks we've encountered. Many of the issues standing in the way of achieving our goals as well as our opportunities are largely within our control. This includes pricing for the Medicare plans, as well as other areas.”

The investigation covers the period between April 2024 and May 12, 2025.

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250513249064/en/

The Unitedhealth Group Stock at the time of publication of the news with a fall of -17,79 % to 311,4EUR on NYSE stock exchange (14. Mai 2025, 02:04 Uhr).